savepiginvest

Vaccibody is now public company listed on Euronext Merkur

OSL:VACC_ME   None
VACCIBODY ENTERS INTO WORLDWIDE LICENSE AND COLLABORATION AGREEMENT WITH GENENTECH, A MEMBER OF THE ROCHE GROUP, TO DEVELOP INDIVIDUALIZED NEOANTIGEN CANCER VACCINES
Vaccibody enters into worldwide, exclusive license and collaboration agreement with Genentech to develop VB10.NEO, individualized neoantigen cancer vaccines
OCTOBER 1, 2020

VACCIBODY LISTS ON OSLO STOCK EXCHANGE’S MERKUR MARKET
Vaccibody Lists on Oslo Stock Exchange’s Merkur Market
OCTOBER 7, 2020

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.